While the direct effects of PI3K inhibition on breast cancer cells are significant, overwhelming research suggests that PI3K inhibition indirectly affects breast cancer cell by targeting the tumor microenvironment (Ali et al., 2014; Peng et al., 2016a; Sai et al., 2017). This evidence concerns the gene PIK3CG and neoplasm.